Genetically modified human placentaderived mesenchymal stem cells with FGF2 and PDGFBB enhance neovascularization in a model of hindlimb ischemia

Author：                        

Publisher： Spandidos Publications

E-ISSN： 1791-3004|12|4|5093-5099

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.4, 2015-01, pp. : 5093-5099

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of placenta-derived mesenchymal stem cells cultured in autologous human cord blood serum

By                        

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 760-766

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model

By                

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 413-418

Spandidos Publications

Access to resources Recommend Favorite

Transplantation of human amniotic mesenchymal stem cells in the treatment of focal cerebral ischemia

By              

Molecular Medicine Reports, Vol. 6, Iss. 3, 2012-01 ,pp. : 625-630

Spandidos Publications

Access to resources Recommend Favorite

Mesenchymal stem cells attenuate acute ischemia-reperfusion injury in a rat model

By              

Experimental and Therapeutic Medicine, Vol. 10, Iss. 6, 2015-01 ,pp. : 2131-2137

Spandidos Publications

Access to resources Recommend Favorite

Fusion of cancer stem cells and mesenchymal stem cells contributes to glioma neovascularization

By Sun Chao   Zhao Dongliang   Dai Xingliang   Chen Jinsheng   Rong Xiaoci   Wang Haiyang   Wang Aidong   Li Ming   Dong Jun   Huang Qiang   Lan Qing  

Oncology Reports, Vol. 34, Iss. 4, 2015-10 ,pp. : 2022-2030

Spandidos Publications

Access to resources Recommend Favorite